Howard Hughes Medical Institute’s LyondellBasell Industries LYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-56
Closed -$2.42K 302
2025
Q4
$2.42K Hold
56
﹤0.01% 456
2025
Q3
$2.75K Hold
56
﹤0.01% 435
2025
Q2
$3.24K Buy
+56
New +$3.26K ﹤0.01% 412
2017
Q3
Sell
-4,084
Closed -$345K 88
2017
Q2
$345K Buy
4,084
+341
+9% +$28.3K 0.06% 108
2017
Q1
$341K Sell
3,743
-2,934
-44% -$268K 0.06% 102
2016
Q4
$573K Buy
+6,677
New +$560K 0.13% 88
2016
Q3
Sell
-454
Closed -$34K 164
2016
Q2
$34K Sell
454
-12,317
-96% -$1.02M 0.01% 154
2016
Q1
$1.09M Sell
12,771
-4,982
-28% -$400K 0.24% 62
2015
Q4
$1.54M Buy
17,753
+2,984
+20% +$275K 0.23% 58
2015
Q3
$1.23M Buy
14,769
+3,331
+29% +$296K 0.23% 59
2015
Q2
$1.18M Buy
11,438
+4,662
+69% +$469K 0.25% 70
2015
Q1
$595K Sell
6,776
-426
-6% -$35.8K 0.08% 92
2014
Q4
$572K Sell
7,202
-973
-12% -$84.4K 0.15% 82
2014
Q3
$888K Buy
8,175
+3,408
+71% +$369K 0.2% 61
2014
Q2
$465K Buy
+4,767
New +$454K 0.08% 59

Other funds holding LYB

Howard Hughes Medical Institute's LYB Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of LyondellBasell Industries (LYB) in Q1 2026, closing a stake of 56 shares — an estimated $2.42K sold.

Howard Hughes Medical Institute first reported a position in LYB in Q2 2014 and held it in 15 quarters. The position peaked at $1.54M in Q4 2015. 927 funds tracked by Wall St. Rank hold LYB as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining LyondellBasell Industries position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 56 LyondellBasell Industries shares in Q1 2026, an estimated $2.42K.
  • Howard Hughes Medical Institute first reported a position in LyondellBasell Industries in Q2 2014 and held it in 15 quarters.
  • Howard Hughes Medical Institute's LyondellBasell Industries position peaked at $1.54M in Q4 2015.
  • 927 funds tracked by Wall St. Rank held LyondellBasell Industries as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.